Trial site
Seoul
- 17running trials
- 17closed trials
The trials here
What the 34 trials at this site are about, from their registry records.
- Conditions
- Asthma5 trials
- Multiple myeloma5 trials
- COPD4 trials
- Atopic dermatitis (eczema)3 trials
- Gastric and oesophageal cancer3 trials
- Lung cancer3 trials
- Metastatic breast cancer2 trials
- Chronic rhinosinusitis with nasal polyps1 trial
- Chronic spontaneous urticaria1 trial
- CIDP (chronic inflammatory demyelinating polyneuropathy)1 trial
- Colorectal cancer1 trial
- Crohn's disease1 trial
- and 7 more
- Phase
- Phase 215 trials
- Phase 313 trials
- Phase 12 trials
- Phase 42 trials
- Phase 1/21 trial
- Status
- Active, not recruiting10 trials
- Completed9 trials
- Terminated8 trials
- Recruiting5 trials
- Enrolling by invitation2 trials
- Lead sponsor
- Sanofi34 trials
Running trials
Recruiting
Recruiting
Recruiting
Recruiting
Active, not recruiting
Enrolling by invitation
Long-term Safety and Efficacy Evaluation of Lunsekimig (SAR443765) in Adult Participants With Asthma
Active, not recruiting
Active, not recruiting
Active, not recruiting
Enrolling by invitation
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Recruiting
Isatuximab in Combination With Novel Agents in RRMM - Master Protocol
Active, not recruiting
Active, not recruiting
Observational Evaluation of Atopic Dermatitis in Pediatric Patients
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- COPD2 recruiting
- Multiple myeloma2 recruiting
- Asthma1 recruiting
- Crohn's disease1 recruiting
Closed trials
Completed
A Study to Investigate Long-term Safety and Tolerability of Itepekimab in Participants With COPD
Completed
Completed
Dose Ranging Study of Amlitelimab in Adult Participants With Moderate-to-severe Asthma
Completed
Proof of Concept Study of Rilzabrutinib in Adult Participants With Moderate-to-severe Asthma
Completed
Completed
Terminated
Terminated
Terminated
Terminated
Terminated
Completed
Completed
Terminated
Terminated
First-in-human Single Agent Study of SAR442257 in RRMM and RR-NHL
Terminated
Completed
Site data: ClinicalTrials.govUpdated 18 Nov 2026